| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |